Logo image of BKDT

BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) Stock Fundamental Analysis

USA - NYSE:BKDT - US1124633025

77.6 USD
-2.09 (-2.62%)
Last: 3/27/2025, 8:04:01 PM
Fundamental Rating

2

BKDT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. BKDT has a bad profitability rating. Also its financial health evaluation is rather negative. BKDT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BKDT had negative earnings in the past year.
In the past year BKDT had a positive cash flow from operations.
BKDT had negative earnings in 4 of the past 5 years.
BKDT had a positive operating cash flow in 4 of the past 5 years.
BKDT Yearly Net Income VS EBIT VS OCF VS FCFBKDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of BKDT (-3.19%) is comparable to the rest of the industry.
The Return On Equity of BKDT (-95.04%) is worse than 76.36% of its industry peers.
BKDT has a Return On Invested Capital of 0.76%. This is comparable to the rest of the industry: BKDT outperforms 42.73% of its industry peers.
Industry RankSector Rank
ROA -3.19%
ROE -95.04%
ROIC 0.76%
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
BKDT Yearly ROA, ROE, ROICBKDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 1.76%, BKDT is in line with its industry, outperforming 47.27% of the companies in the same industry.
In the last couple of years the Operating Margin of BKDT has grown nicely.
BKDT's Gross Margin of 25.57% is in line compared to the rest of the industry. BKDT outperforms 50.91% of its industry peers.
BKDT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.76%
PM (TTM) N/A
GM 25.57%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
BKDT Yearly Profit, Operating, Gross MarginsBKDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

0

2. Health

2.1 Basic Checks

BKDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BKDT has been increased compared to 1 year ago.
Compared to 5 years ago, BKDT has more shares outstanding
The debt/assets ratio for BKDT has been reduced compared to a year ago.
BKDT Yearly Shares OutstandingBKDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BKDT Yearly Total Debt VS Total AssetsBKDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.14, we must say that BKDT is in the distress zone and has some risk of bankruptcy.
BKDT's Altman-Z score of 1.14 is on the low side compared to the rest of the industry. BKDT is outperformed by 63.64% of its industry peers.
BKDT has a Debt/Equity ratio of 20.19. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 20.19, BKDT is not doing good in the industry: 84.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 20.19
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACC0.09
WACC8.64%
BKDT Yearly LT Debt VS Equity VS FCFBKDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

BKDT has a Current Ratio of 0.88. This is a bad value and indicates that BKDT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BKDT (0.88) is worse than 78.18% of its industry peers.
BKDT has a Quick Ratio of 0.88. This is a bad value and indicates that BKDT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.88, BKDT is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
BKDT Yearly Current Assets VS Current LiabilitesBKDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BKDT have decreased by -5.95% in the last year.
Looking at the last year, BKDT shows a small growth in Revenue. The Revenue has grown by 3.63% in the last year.
The Revenue has been decreasing by -5.08% on average over the past years.
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%

3.2 Future

The Earnings Per Share is expected to grow by 18.13% on average over the next years. This is quite good.
Based on estimates for the next years, BKDT will show a small growth in Revenue. The Revenue will grow by 2.10% on average per year.
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BKDT Yearly Revenue VS EstimatesBKDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
BKDT Yearly EPS VS EstimatesBKDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

1

4. Valuation

4.1 Price/Earnings Ratio

BKDT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKDT Price Earnings VS Forward Price EarningsBKDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BKDT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.27
BKDT Per share dataBKDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BKDT's earnings are expected to grow with 18.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.51%, BKDT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.55, BKDT pays a better dividend. On top of this BKDT pays more dividend than 97.27% of the companies listed in the same industry.
BKDT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 4.51%

5.2 History

BKDT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BKDT Yearly Dividends per shareBKDT Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3

5.3 Sustainability

DPN/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%
BKDT Yearly Income VS Free CF VS DividendBKDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

BROOKDALE SENIOR LIVING - BKD 7 11/15/25

NYSE:BKDT (3/27/2025, 8:04:01 PM)

77.6

-2.09 (-2.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)05-05 2025-05-05
Inst Owners106.89%
Inst Owner ChangeN/A
Ins Owners3.68%
Ins Owner ChangeN/A
Market Cap15.53B
Revenue(TTM)3.13B
Net Income(TTM)-201.94M
Analysts73.33
Price Target105.12 (35.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.51%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date02-14 2025-02-14 (0.875)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.06%
Min EPS beat(2)-74.45%
Max EPS beat(2)-25.67%
EPS beat(4)1
Avg EPS beat(4)-21.47%
Min EPS beat(4)-74.45%
Max EPS beat(4)26.45%
EPS beat(8)3
Avg EPS beat(8)-5.89%
EPS beat(12)4
Avg EPS beat(12)-2.98%
EPS beat(16)7
Avg EPS beat(16)16.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.88%
Revenue beat(12)0
Avg Revenue beat(12)-0.72%
Revenue beat(16)0
Avg Revenue beat(16)-1.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)10.25%
EPS NQ rev (3m)22.22%
EPS NY rev (1m)8.42%
EPS NY rev (3m)8.42%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.97
P/FCF N/A
P/OCF 93.48
P/B 73.11
P/tB 83.9
EV/EBITDA 46.27
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)0.83
OCFY1.07%
SpS15.61
BVpS1.06
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.19%
ROE -95.04%
ROCE 0.96%
ROIC 0.76%
ROICexc 0.8%
ROICexgc 0.81%
OM 1.76%
PM (TTM) N/A
GM 25.57%
FCFM N/A
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 20.19
Debt/FCF N/A
Debt/EBITDA 10.15
Cap/Depr 84.26%
Cap/Sales 9.91%
Interest Coverage 0.23
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z 1.14
F-Score6
WACC8.64%
ROIC/WACC0.09
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A
EBIT growth 1Y142.36%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year517.25%
EBIT Next 3Y97.55%
EBIT Next 5YN/A
FCF growth 1Y-102.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2%
OCF growth 3YN/A
OCF growth 5Y-5.14%

BROOKDALE SENIOR LIVING - BKD 7 11/15/25 / BKDT FAQ

Can you provide the ChartMill fundamental rating for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?

ChartMill assigns a fundamental rating of 2 / 10 to BKDT.


Can you provide the valuation status for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?

ChartMill assigns a valuation rating of 1 / 10 to BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT). This can be considered as Overvalued.


What is the profitability of BKDT stock?

BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) has a profitability rating of 3 / 10.


What is the earnings growth outlook for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?

The Earnings per Share (EPS) of BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) is expected to grow by 34.18% in the next year.